Brought to you by 
Asklepios raises $235mm in first round; TPG and Vida take minority stakes
26 Apr 2021
Executive Summary
Asklepios BioPharmaceutical Inc. (AskBio; gene therapies) raised $235mm in what appears to be the company's first organized venture funding round. TPG and Vida Ventures invested $225mm and now hold minority stakes in the firm, while founders and board members contributed the other $10mm.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Asklepios raises $235mm in first round; TPG and Vida take minority stakes
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice